CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 50 target
Drug / intervention
Trivalent Inactivated Influenza Vaccinebiological
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00402805
NCT00402805Phase 4Completed
CompareCT.gov

Improving the Humoral Response to Influenza Vaccine in Lung Transplant Recipients by an Intradermal Strategy

University Health Network, Toronto·interventional·Posted Nov 22, 2006·Updated Apr 16, 2008

In Brief

A Phase 4 clinical trial evaluating Trivalent Inactivated Influenza Vaccine for Lung Transplantation and Influenza Vaccines. Completed, enrolled 50 participants across 1 site.

Detailed Summary

The purpose of this study is to test the specific humoral response after an intramuscular and intradermal influenza vaccination in lung transplant recipients

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsLung Transplantation, Influenza Vaccines
CountriesCanada
Collaborators--

Timeline

Phase 4CompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedNov 22, 2006
Enrollment StartOct 1, 2006
Primary CompletionFeb 1, 2007
Study CompletionJul 1, 2007
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 19.6 years ago

Interventions

Trivalent Inactivated Influenza Vaccinebiological